Jang YN, Lee JH, Moon JS, Kang DR, Park SY, Cho J, Kim JY, Huh JH (2021) Metabolic syndrome severity score for predicting cardiovascular events: a nationwide population-based study from Korea. Diabetes Metab J 45(4):569–577. https://doi.org/10.4093/dmj.2020.0103

Article  PubMed  PubMed Central  Google Scholar 

DeBoer MD, Filipp SL, Gurka MJ (2020) Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting versus non-fasting individuals. Nutr Metabol Cardiovas Diseases 30(1):92–98. https://doi.org/10.1016/j.numecd.2019.08.010

Article  Google Scholar 

Qasim SF, Jami A, Imran P, Mushtaque R, Khan RN (2020) Frequency of metabolic syndrome in chronic hepatitis C patients: findings from a lower middle income country. Cureus 12(12):e11975. https://doi.org/10.7759/cureus.11975

Article  PubMed  PubMed Central  Google Scholar 

Grassi G (2016) Hepatitis C virus relies on lipoproteins for its life cycle. World J Gastroenter 22(6):1953. https://doi.org/10.3748/wjg.v22.i6.1953

Article  CAS  Google Scholar 

Engin A (2017) The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol 960:1–17. https://doi.org/10.1007/978-3-319-48382-5_1

Article  CAS  PubMed  Google Scholar 

Regufe VMG, Pinto CMCB, Perez PMVHC (2020) Metabolic syndrome in type 2 diabetic patients: a review of current evidence. Porto Biomed J 5(6):e101. https://doi.org/10.1097/j.pbj.0000000000000101

Article  PubMed  PubMed Central  Google Scholar 

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419. https://doi.org/10.1007/BF00280883

Article  CAS  PubMed  Google Scholar 

Diniz MFHS, Beleigoli AMR, Schmidt MI, Duncan BB, Ribeiro ALP, Vidigal PG, Benseñor IM, Lotufo PA, Santos IS, Griep RH, Barreto SM (2020) Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study. Cad Saude Publica 36(8):e00072120. https://doi.org/10.1590/0102-311X00072120

Article  PubMed  Google Scholar 

Oliveira LP, Jesus RP, Boulhosa RS, Mendes CM, Lyra AC, Lyra LG (2012) Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes. Clinics (Sao Paulo) 67(3):219–223. https://doi.org/10.6061/clinics/2012(03)03

Article  PubMed  Google Scholar 

Fasting for a Blood Test. https://medlineplus.gov/lab-tests/fasting-for-a-blood-test/#:~:text=You%20usually%20need%20to%20fast,test%20early%20in%20the%20morning. Last accessed [1–10–2024].

Insulin in Blood. https://medlineplus.gov/lab-tests/insulin-in-blood/#:~:text=Your%20health%20care%20provider%20will,a%20day%20before%20your%20test. last accessed [1–10–2024].

Testing for Cholesterol. https://www.cdc.gov/cholesterol/testing/index.html#:~:text=What%20do%20I%20need%20to,to%20prepare%20for%20the%20test. last accessed [1–10–2024].

Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report 106(25): 3143–421.

Metabolic Syndrome Severity Calculator. https://metscalc.org/metscalc/. last accessed [1–10–2024].

Cassia De, da Silva C, Zambon MP, Vasques ACJ, Camilo DF, Antonio DGM (2023) The threshold value for identifying insulin resistance (HOMA-IR) in an admixed adolescent population a hyperglycemic clamp validated study. Arch Endocrinol Metab. https://doi.org/10.20945/2359-3997000000533

Article  Google Scholar 

Nuttall FQ (2015) Body mass index: obesity, BMI, and health: a critical review. Nutr Today 50(3):117–128. https://doi.org/10.1097/NT.0000000000000092

Article  PubMed  PubMed Central  Google Scholar 

Flack JM, Adekola B (2020) Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med 30(3):160–164. https://doi.org/10.1016/j.tcm.2019.05.003

Article  PubMed  Google Scholar 

Shimada M, Kawahara H, Ozaki K, Fukura M, Yano H, Tsuchishima M, Tsutsumi M, Takase S (2007) Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. Am J Gastroenterol 102(9):1931–1938. https://doi.org/10.1111/j.1572-0241.2007.01322.x

Article  CAS  PubMed  Google Scholar 

Bose SK, Ray R (2014) Hepatitis C virus infection and insulin resistance world J. Diabetes 5(1):52–58. https://doi.org/10.4239/wjd.v5.i1.52

Article  Google Scholar 

DeBoer MD, Lin B, Filipp SL, Cusi K, Gurka MJ (2021) Severity of metabolic syndrome is greater among nonalcoholic adults with elevated ALT and advanced fibrosis. Nutr Res 88:34–43. https://doi.org/10.1016/j.nutres.2020.12.023

Article  CAS  PubMed  Google Scholar 

Isaac A, Abd El-Mageed KH, Kaisar HH, Rasmy HS, Ghait RS, Ibrahim IM (2021) Assessment of serum Resistin in detecting insulin resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patients. Egyptian Liver J 11(1):65. https://doi.org/10.1186/s43066-021-00136-1

Article  Google Scholar 

Shawky MA, Mohammed AQ, Hassan AM, Ali BH, Moustafa HM (2020) Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus. Rev Gastroenterol Mex (Engl Ed) 85(2):173–179. https://doi.org/10.1016/j.rgmx.2019.05.005

Article  CAS  PubMed  Google Scholar 

Mehta SH (2000) Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Inter Med 133(8):592. https://doi.org/10.7326/0003-4819-133-8-200010170-00009

Article  CAS  Google Scholar 

Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A (2000) Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 75(4):355–359. https://doi.org/10.4065/75.4.355

Article  CAS  PubMed  Google Scholar 

Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P (2008) Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 134(2):416–423. https://doi.org/10.1053/j.gastro.2007.11.010

Article  CAS  PubMed  Google Scholar 

Gitto S, Cicero AFG, Loggi E, Giovannini M, Conti F, Grandini E, Guarneri V, Scuteri A, Vitale G, Cursaro C, Borghi C, Andreone P (2018) Worsening of serum lipid profile after direct acting antiviral treatment. Ann Hepatol 17(1):64–75. https://doi.org/10.5604/01.3001.0010.7536

Article  CAS  PubMed  Google Scholar 

Liang C, Yu Z, Bai L, Hou W, Tang S, Zhang W, Chen X, Hu Z, Duan Z, Zheng S (2022) Association of serum bilirubin with metabolic syndrome and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 13:869579. https://doi.org/10.3389/fendo.2022.869579

Article  PubMed  Google Scholar 

Chen L, Dai J, Xie Q, Wang X, Cai W (2022) Metabolic risk factors are associated with the disease severity and prognosis of hepatitis B virus-related acute on chronic liver failure. GUT Liver. https://doi.org/10.5009/gnl210449

Article  PubMed  PubMed Central  Google Scholar 

Dahal S, Upadhyay S, Banjade R, Dhakal P, Khanal N, Bhatt VR (2017) Thrombocytopenia in patients with chronic hepatitis C virus infection. Mediterr J Hematol Infect Dis 9(1):e2017019. https://doi.org/10.4084/MJHID.2017.019

Article  PubMed  PubMed Central  Google Scholar 

Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S (2021) Abnormal liver enzymes: a review for clinicians. World J Hepatol. https://doi.org/10.4254/wjh.v13.i11.1688

Article  PubMed  PubMed Central  Google Scholar 

Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC (2009) Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 49(2):225–232. https://doi.org/10.1086/599371

Article  PubMed  Google Scholar 

Giordanino C, Bugianesi E, Smedile A, Ciancio A, Abate ML, Olivero A, Pellicano R, Cassader M, Gambino R, Bo S, Ciccone G, Rizzetto M, Saracco G (2008) Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Am J Gastroenterol. https://doi.org/10.1111/j.1572-0241.2008.02002.x

Article  PubMed  Google Scholar 

Aby ES, Dong TS, Kawamoto J, Pisegna JR, Benhammou JN (2017) Impact of sustained virologic response on chronic kidney disease progression in hepatitis C. World J Hepatol 36:1352–1360. https://doi.org/10.4254/wjh.v9.i36.1352